<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480985</url>
  </required_header>
  <id_info>
    <org_study_id>C14-06-2040-21</org_study_id>
    <nct_id>NCT02480985</nct_id>
  </id_info>
  <brief_title>The PIT-TBI Pilot Study</brief_title>
  <official_title>Clinical Outcomes and Predictors of PITuitary Disorders in Patients With Moderate and Severe Traumatic Brain Injury: the PIT-TBI Prospective Multicenter Pilot Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Critical Care Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Damage to the pituitary gland is a frequently overlooked but potentially important
      complication of traumatic brain injury (TBI). Disorders of the pituitary gland can cause
      dysfunction of the thyroid, adrenals, ovaries and testes. These disorders may occur
      immediately or several months after TBI, may delay recovery and may have a significant
      negative impact on quality of life. TBI is the leading cause of disability and major
      permanent functional impairment among adults under 45 years of age. Hormonal deficits may
      contribute to common symptoms experienced by TBI survivors such as fatigue, poor
      concentration, depression and low exercise capacity. However, the association between
      hormonal deficits and disability remains uncertain. The primary objective of this pilot study
      is to assess the feasibility of a larger study that will evaluate the impact of pituitary
      disorders on neurological disability and functional recovery. The results of this study will
      provide key findings in the impact of pituitary disorders following TBI, which is a mandatory
      step prior testing the effect of hormonal replacement therapy in this population in costly
      clinical trials. If no relationship between pituitary disorders and disability is observed,
      the investigators' findings will prevent unnecessary, time-consuming and costly hormonal
      screening and will discourage potentially harmful hormonal therapy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to the Protocol</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of participants who underwent pituitary function evaluation and outcome measures as detailed in the Assigned Interventions section</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Enrollment Rate</measure>
    <time_frame>12 months</time_frame>
    <description>Number of patients recruited per month per site</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurological Recovery</measure>
    <time_frame>12 months</time_frame>
    <description>Glasgow Outcome Scale Extended (GOSe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>EuroQuol - EQ-5D-5L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Independent functioning</measure>
    <time_frame>12 months</time_frame>
    <description>Functional Independence Measure (FIM) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>12 months</time_frame>
    <description>Patient Health Questionnaire (PHQ-9)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life satisfaction</measure>
    <time_frame>12 months</time_frame>
    <description>Life Satisfaction Questionnaire (LISAT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary hypothyroidism</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary hypogonadism</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary adrenal insufficiency</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth hormone deficit</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pituitary Disorders</condition>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Pituitary function evaluation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Exams performed according to a determined schedule following admission in the intensive care unit in order to determine the risk factors and the outcome associated with pituitary disorders.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pituitary function evaluation</intervention_name>
    <description>Pituitary function evaluation performed at hospital discharge, 6 and 12 months
Thyroid-stimulating hormone, free T4 and T3
Follicle stimulating hormone, luteinizing hormone, estradiol, bioavailable testosterone
Adrenocorticotropic hormone stimulation test
Glucagon test (growth hormone deficit)
Risk factors evaluation of pituitary dysfunction
Demographic data
Daily data (clinical exam, secondary brain injuries)
Hormone levels on day 1, 3 and 7
Biomarkers on day 1, 3 and 7
Brain CT-Scan on day 1
Pituitary MRI on day 7
Outcome measures at 6 and 12 months
Neurological recovery (GOSe)
Independent functioning (FIM)
Quality of life (EQ-5D-5L)
Life satisfaction (LISAT-11)
Depression (PHQ-9)</description>
    <arm_group_label>Pituitary function evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (≥ 18 years old)

          -  Severe or moderate blunt TBI admitted to the ICU with a Glasgow Coma Scale ≤ 12
             following initial resuscitation

        Exclusion Criteria:

          -  Previously diagnosed or suspected pituitary disorder or disease

          -  Pregnant or lactating woman

          -  Penetrating TBI

          -  Solid malignancy with life expectation &lt;12 months

          -  Liver Cirrhosis Child C

          -  Chronic Heart Failure (New York Heart Association class IV)

          -  End-stage chronic respiratory disease (O2 dependent)

          -  End-stage renal disease (chronic dialysis or to be expected)

          -  Neurological conditions influencing functional status (e.g. spinal cord injury,
             neuromuscular disease, dementia, prior TBI or stroke)

          -  No fixed address

          -  Physician refusal

          -  Brain death

          -  Unable to return to the study center to attend the follow-up visits

          -  Admission to the Intensive Care Unit of the participating center &gt; 24 hours after TBI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Lauzier, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Quebec Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacré-Coeur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Sherbrooke - Hôpital Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Québec - Hôpital de l'Enfant-Jésus</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.ccctg.ca</url>
  </link>
  <link>
    <url>http://www.criticalcare-neurotrauma.ca</url>
  </link>
  <reference>
    <citation>Lauzier F, Turgeon AF, Boutin A, Shemilt M, Côté I, Lachance O, Archambault PM, Lamontagne F, Moore L, Bernard F, Gagnon C, Cook D. Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review. Crit Care Med. 2014 Mar;42(3):712-21. doi: 10.1097/CCM.0000000000000046. Review.</citation>
    <PMID>24247474</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHU de Quebec-Universite Laval</investigator_affiliation>
    <investigator_full_name>François Lauzier</investigator_full_name>
    <investigator_title>MD MSc FRCPC</investigator_title>
  </responsible_party>
  <keyword>Pituitary Disorders</keyword>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Outcome Research</keyword>
  <keyword>Risk Factors</keyword>
  <keyword>Patient Oriented Research</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Pituitary Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

